Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Knight

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|March 4, 2000
Five years of percutaneous transluminal septal myocardial ablationC J Knight
Heart (British Cardiac Society)|April 17, 2001
National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?C J Knight
Heart (British Cardiac Society)|November 23, 2005
Modern management of myocardial infarction: introductionC J Knight
Life Support Systems : the Journal of the European Society for Artificial Organs|April 1, 1983
Venture capital or vulture capital?C J Knight
International Journal of Cardiology|March 15, 2000
Haematological abnormalities in rheumatic mitral valve diseaseC J Knight
Hospital Medicine (London, England : 1998)|March 10, 2001
Current management of hypertrophic cardiomyopathyP Golledge, C J Knight
Helvetica Chirurgica Acta|June 1, 1980
[New approaches in ECG automatic monitoring in intensive care]C J Knight, J Belenger
Journal of Cardiovascular Risk|June 1, 1995
Cholesterol and the coronary endotheliumC J Knight, J B Warren
The American Journal of Cardiology|May 20, 1998
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) InvestigatorsC J Knight, K M Fox
Heart (British Cardiac Society)|December 18, 2004
Wire artefact--in reverse!R A Archbold, C J Knight
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|March 4, 2000
Five years of percutaneous transluminal septal myocardial ablationC J Knight
Heart (British Cardiac Society)|April 17, 2001
National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?C J Knight
Heart (British Cardiac Society)|November 23, 2005
Modern management of myocardial infarction: introductionC J Knight
Life Support Systems : the Journal of the European Society for Artificial Organs|April 1, 1983
Venture capital or vulture capital?C J Knight
International Journal of Cardiology|March 15, 2000
Haematological abnormalities in rheumatic mitral valve diseaseC J Knight
Hospital Medicine (London, England : 1998)|March 10, 2001
Current management of hypertrophic cardiomyopathyP Golledge, C J Knight
Helvetica Chirurgica Acta|June 1, 1980
[New approaches in ECG automatic monitoring in intensive care]C J Knight, J Belenger
Journal of Cardiovascular Risk|June 1, 1995
Cholesterol and the coronary endotheliumC J Knight, J B Warren
The American Journal of Cardiology|May 20, 1998
Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) InvestigatorsC J Knight, K M Fox
Heart (British Cardiac Society)|December 18, 2004
Wire artefact--in reverse!R A Archbold, C J Knight
Pageof 5